Recruiting studies: Cervical Squamous Cell Carcinoma In Situ

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851 VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NA · 4 location(s) · Olgun Elicin · NCT04057209 NWRD09 for HPV-16 Related Cervical HSIL
Phase 1 · 1 location(s) · Newish Biotech (Wuxi) Co., Ltd. · NCT07047989 A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients
Phase 1 · 16 location(s) · OncoNano Medicine, Inc. · NCT06022029 Efficacy and Safety of Photodynamic Therapy for CIN3
NA · 1 location(s) · Peking University Third Hospital · NCT07009327 Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902 Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270 Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL
Phase 2 · 5 location(s) · Newish Biotech (Wuxi) Co., Ltd. · NCT07175662

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.